Mantini, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 3.666
EU - Europa 3.608
AS - Asia 2.497
SA - Sud America 525
AF - Africa 69
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 10.398
Nazione #
US - Stati Uniti d'America 3.538
DE - Germania 1.511
SG - Singapore 1.194
CN - Cina 689
SE - Svezia 602
BR - Brasile 443
IT - Italia 278
UA - Ucraina 276
FR - Francia 227
GB - Regno Unito 171
IN - India 153
IE - Irlanda 140
VN - Vietnam 100
ID - Indonesia 98
CA - Canada 85
PL - Polonia 77
RU - Federazione Russa 76
FI - Finlandia 66
TR - Turchia 60
BE - Belgio 43
BD - Bangladesh 31
CZ - Repubblica Ceca 31
AR - Argentina 28
JP - Giappone 26
MX - Messico 20
NL - Olanda 20
HK - Hong Kong 19
EC - Ecuador 17
IQ - Iraq 17
ZA - Sudafrica 17
AU - Australia 16
ES - Italia 16
AT - Austria 15
CI - Costa d'Avorio 15
SA - Arabia Saudita 15
IR - Iran 14
CL - Cile 11
UZ - Uzbekistan 11
BZ - Belize 10
MA - Marocco 10
AZ - Azerbaigian 9
CH - Svizzera 9
JO - Giordania 9
PT - Portogallo 9
VE - Venezuela 9
EU - Europa 8
KE - Kenya 8
KR - Corea 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
CO - Colombia 5
KZ - Kazakistan 5
NO - Norvegia 5
PE - Perù 5
PK - Pakistan 5
DK - Danimarca 4
DZ - Algeria 4
HU - Ungheria 4
IL - Israele 4
PH - Filippine 4
RO - Romania 4
TN - Tunisia 4
BG - Bulgaria 3
BO - Bolivia 3
ET - Etiopia 3
JM - Giamaica 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
MN - Mongolia 1
MW - Malawi 1
NA - Namibia 1
Totale 10.390
Città #
Chandler 666
Singapore 550
Ashburn 305
Jacksonville 156
Ann Arbor 145
Beijing 142
Dublin 139
San Mateo 138
Nanjing 107
Nürnberg 100
Dearborn 98
Houston 96
Jakarta 90
Woodbridge 83
Wilmington 81
New York 77
Los Angeles 70
Boston 68
Munich 68
Warsaw 61
Redwood City 57
Frankfurt am Main 53
Marseille 51
São Paulo 47
The Dalles 47
Bremen 46
Nanchang 46
Cattolica 45
Fairfield 45
Milan 45
Izmir 44
Princeton 44
Moscow 43
Brussels 42
Redmond 38
Hefei 37
Lawrence 37
Dallas 34
Buffalo 31
Ho Chi Minh City 31
Rome 31
Toronto 31
Seattle 29
San Jose 27
Hanoi 26
Hebei 22
Leawood 22
North York 21
Kunming 20
Chicago 19
Tianjin 19
Hangzhou 18
Hong Kong 18
Jiaxing 18
Shenyang 18
Shanghai 17
Mountain View 16
Tokyo 16
Abidjan 15
Boardman 15
London 15
Brasília 14
Düsseldorf 14
Helsinki 14
Santa Clara 14
Albuquerque 13
San Francisco 13
Stockholm 13
Zhengzhou 13
Enterprise 12
Guangzhou 12
Hyderabad 12
Rio de Janeiro 12
San Diego 12
Washington 12
Andover 11
Changsha 11
Lauterbourg 11
Ottawa 11
Phoenix 11
Atlanta 10
Belize City 10
Tashkent 10
Amman 9
Brooklyn 9
Falls Church 9
Fremont 9
University Park 9
Amsterdam 8
Baku 8
Bexley 8
Cambridge 8
Lancaster 8
Las Vegas 8
Norwalk 8
Paris 8
Pune 8
Quito 8
Vienna 8
Augusta 7
Totale 4.941
Nome #
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 292
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 266
Pros-IT CNR: an Italian prostate cancer monitoring project 263
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 245
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 209
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 204
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 194
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 192
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 184
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 183
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 182
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 180
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 177
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 173
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 172
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 170
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 168
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 165
Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases 162
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study 162
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 157
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 156
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 154
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study 149
Radiotherapy vs Follow up in the treatment of pathological stage Ia and Ib non small cell lung cancer. Early stopped analysis of a randomized controlled study. 148
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 147
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 147
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial 147
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 146
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 146
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 142
Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome 142
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 137
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 137
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy. 134
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 133
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 129
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 129
Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis. 128
Role of radiotherapy in the treatment of fibrosarcoma of the spermatic cord: a case report and review of the literature 124
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 120
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 120
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 117
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 115
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 114
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 111
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 104
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 104
Can automation in radiotherapy reduce costs? 103
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 102
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 102
OncotypeDX (R) predictive nomogram for recurrence score output: A machine learning system based on quantitative immunochemistry analysis-ADAPTED01 102
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 99
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 98
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 96
Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial 96
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 95
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology 94
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 94
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 91
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 90
Breakthrough pain management in patients undergoing radiotherapy: A national survey on behalf of the Palliative and Supportive Care Study Group 87
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 86
Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy 86
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: Low-dose fractionated radiotherapy with concurrent chemotherapy 86
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 84
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 82
Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial 81
Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: Rototranslational shift and dosimetric consequences 79
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 78
Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma 78
BIT-ART: Multicentric comparison of HDR-brachytherapy, intensity-modulated radiotherapy and tomotherapy for advanced radiotherapy in prostate cancer 77
Radiotherapy plus GnRH analogue versus high dose bicalutamide: A case control study 75
776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER 74
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 67
Impact of dose and volume on radiation-induced mucositis 61
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: An Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study 57
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study 54
External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study 53
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 47
Split course concomitant radiochemotherapy followed by brachytherapy boost in the exclusive treatment of the anal canal cancer 43
Preoperative radiotherapy in gastric cancer: CTV definition for conformal therapy according to tumor location 41
Spider: Managing clinical data of cancer patients treated through a multidisciplinary approach by a palm based system 38
Chemoradiation with raltitrexed (TOMUDEX) in preoperative treatment of stage II-III resectable rectal cancer: A phase II study 36
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure 32
Quality handbook in radiotherapy: personal experience 29
Totale 10.553
Categoria #
all - tutte 41.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021377 0 0 0 0 0 53 84 27 86 37 81 9
2021/2022849 77 57 16 58 52 45 27 134 34 67 132 150
2022/20231.770 254 250 149 303 102 208 88 126 203 13 47 27
2023/2024724 33 207 20 69 29 95 16 55 11 22 78 89
2024/20251.541 49 49 118 55 149 41 26 72 250 151 324 257
2025/20261.915 592 96 188 345 672 22 0 0 0 0 0 0
Totale 10.553